Planned Transition to Sirolimus-Based Therapy vs. Continued Tacrolimus-Based Therapy in Renal Allograft Recipients

Grants and Contracts Details

StatusFinished
Effective start/end date10/8/09 → 6/30/14

Funding

  • Wyeth Pharmaceuticals Inc: $172,778.00